00:01
So let's talk through some of the
more common seizure medications
that we use clinically, and that
you'll see on a clinical vignette.
00:08
And we'll discuss the key points,
the dosing considerations,
some of the side effects,
and clinical pearls
for using that agent.
00:15
We'll start with phenytoin.
00:17
This is one of our
older seizure medicines.
00:19
It's been around for a long time.
It's used commonly in the clinic.
00:22
And we know a lot about it.
00:24
It's an old agent.
It's an enzyme inducer,
it's a hepatic inducer
as with our other older
anti-epileptics.
00:31
Carbamazepine and phenobarbital
it induces the metabolism
of other medications.
00:36
And so we can see the
lower drug levels of medicines
that are metabolized hepatically.
00:41
And it is highly protein bound,
which means it'll have
drug-drug interactions
with other selected agents.
00:48
When we're loading
this medicine,
and specifically when we're
treating status epilepticus
the loading formulation
is fosphenytoin.
00:55
And that's the IV formulation
is has faster onset,
less irritation to the veins,
and likely less cardiotoxicity.
01:02
Some of the side effects
to think about with phenytoin
it's a sodium channel active agent,
so it can cause nausea,
vomiting, ataxia, tremor,
rarely an allergic hepatitis
can be seen.
01:13
And the long term
side effects and toxicities
that we think about
are gingival hyperplasia,
osteoporosis, cerebellar atrophy,
and sometimes neuropathy.
01:22
Those are commonly tested
long-term complications
or side effects of this medication.
01:28
It's also a medicine that has
zero-order pharmacokinetics.
01:31
And this means that
small dose adjustments
lead to large changes
in the serum concentration.
01:37
We typically use doses between
100 milligrams, three times a day,
or 300 milligrams at night,
to 400-500,
or rarely 600 milligrams.
01:45
And again, small adjustments leads
to large changes in concentration.
01:50
It is highly protein bound.
01:52
And so this can cause
drug-drug interactions,
as well as in patients
with malnutrition.
01:58
We can see adjustment in the dose.
02:00
We must correct Dilantin levels
for albumin concentration
and given that
protein-protein binding,
or nowadays, we frequently check
free phenytoin in levels
to get at the actual
serum concentration for patients.
02:16
What about Depakote
or valproic acid?
Again, this is one of our
older anti-epileptics.
02:21
It's effective,
very effective for both
focal onset and generalized
onset epilepsies.
02:26
It is not an
enzyme inducing agent.
02:28
It is an enzyme inhibiting agents.
So it's a hepatic inhibitor.
02:32
It inhibits hepatic metabolism
of various agents
and can increase
their drug levels.
02:38
So we always check for
drug-drug interactions,
when starting this medication.
02:43
There are a number of side effects
that we need to think about
with this medicine.
02:46
It can result in
fatal liver toxicity
which is extremely rare.
02:50
It can be seen in children
less than two years of age,
who have errors
of inborn metabolism.
02:56
And so those are important
to screen for on a history
or consider when using
in young children.
03:01
It can result in pancreatitis,
which is an idiosyncratic reaction,
meaning it can happen
at any point of time,
not just when you
start the drug
or those who have been on it
in a long time,
at any point in time
during their treatment.
03:14
It can produce hair loss,
and we treat that typically
with zinc and selenium,
as well as thrombocytopenia
and weight gain.
03:20
It's also a teratogen.
03:22
And that's something
that we need to consider
when prescribing this to patients
who could be of childbearing age.
03:26
It is another
protein-bound medication.
03:29
So when we use Dilantin, and
Depakote, or valproic acid together,
we need to consider
that one drug may increase
the levels of the other.
03:36
And important notes,
it's the least risk of causing
skin hypersensitivity reaction.
03:42
There are a number of
seizure medications
that can cause severe rash
and this is the least
likely to do that.
03:47
And it also works as a
very good mood stabilizer
and a migraine
prophylactic medicine.
03:53
And so we typically consider
it in patients
who also have migraines,
or may benefit
from mood stabilization.
04:00
Tegretol or carbamazepine is also
one of our older seizure medicines,
and it's frequently used.
04:06
It's the most widely used
anti-epileptic drug in the world.
04:10
It is an auto-inducer
of its own metabolism.
04:12
And it's also an enzyme inducer,
hepatic enzyme inducer.
04:16
So it induces the metabolism
of other medications
that are statically cleared
and can lower their drug levels.
04:24
Side effects that we think about
with Tegretol or carbamazepine,
are hyponatremia,
which we monitor
with a blood chemistry.
04:31
Agranularcytosis, which is uncommon,
but very important to recognize,
and it causes other
sodium channel side effects.
04:38
Nausea, vomiting, problems with
imbalance or discoordination.
04:44
I think it's also good to mention
that Tegretol can be used
for trigeminal neuralgia.
04:48
It can have some mood stabilization
properties in patients.
04:52
And it is also used
in some pain syndromes
where it can help control
effective transmission.
05:00
Levetiracetam is one of the most
commonly used first line agents
for treating epilepsy.
05:04
It's metabolized in the
kidneys and not the liver.
05:08
And so that's an important
difference with this medication.
05:10
It does have some
anti-epileptic properties.
05:13
Many of our seizure drugs
help to reduce seizures,
but don't prevent long-term
continuation of the epilepsy.
05:20
Patients who are on
levetiracetam
are more likely to become
seizure free
and be able to come off
their medication.
05:27
Side effects are similar
to all anti-epileptic drugs
include sedation.
05:31
And about 5% of adults,
and somewhere between
5 to 25% of kids
may have increase in irritability,
or agitation, or mood changes
on this medication.
05:41
This can be loaded IV.
05:42
And there's a one-to-one ratio
of IV to PO dosing.
05:46
And typically, the
maintenance doses are around
3,000 to 4000 milligrams a day.
05:50
There's not really a ceiling.
05:51
Patients don't develop
dose dependent side effects,
but we tend to see
reduced efficacy in doses higher
than these that you see here.
05:59
How about Topamax or topiramate?
This is a great medication.
06:03
It's used both for seizures and it's
a medication effective for migraine.
06:07
So in seizure patients who have
severe migraines or headaches,
we commonly think
about this medication.
06:13
It can slow cognition.
06:14
We can see cognitive slowing
or bradyphrenia.
06:16
And the main side effect
that we see
it as a dose dependent
side effect.
06:21
Some of the other side effects,
we see reduced body weight.
06:23
So patients can lose weight
on this medication.
06:26
Sometimes that's
a beneficial side effect,
other times, it's something
we need to avoid.
06:30
Other side effects include
dizziness, confusion,
drowsiness, paraesthesias,
impaired memory, and slowed
responsiveness, or speed of thought
is really what patients describe.
06:40
And importantly,
it can cause painful,
closed-angle glaucoma.
06:45
And that's important to screen for
in patients who have
head pain and a red eye.
06:49
Patients need to be evaluated
by an ophthalmologist emergently.
06:54
Interestingly,
topiramate as well as zonisamide
have carbonic anhydrase
inhibitor properties.
07:01
And this is active in the liver
resulting in metabolic acidosis,
hypercalciuria, and an
increased risk of kidney stones.
07:08
So we need to screen for
kidney stones in these patients.
07:11
And patients who have
recurrent kidney stones
should be counseled on
aggressive hydration
are really considered
for another anti-epileptic
besides topiramate and zonisamide.
07:23
And then lastly,
we'll talk about lamotrigine.
07:25
This is a very safe
and highly effective agent.
07:27
It is category C in pregnancy.
07:29
So that's one of the
safest anti-epileptic drugs
that we have for use in pregnancy
or the postpartum period.
07:35
It has a broad spectrum
of activity.
07:37
We use it for focal onset epilepsy
and generalized onset epilepsy.
07:41
The main thing to consider
with this agent is rash.
07:44
It's very safe.
We see very few side effects.
07:47
It's also used as a mood
stabilizer and can help with pain.
07:51
But patients can develop
Stevens-Johnson syndrome,
a very severe rash,
that develops when patients
begin on this medicine
at too fast or rapid of a dose.
08:01
So typically,
we begin in a very low dose
and the titration period is
often between 8 to 10 weeks,
when patients are slowly
brought on to a therapeutic dose.
08:11
So this medication
is not one that we use
when we need to treat
seizures now.
08:15
But can be begun
or add as an adjunctive agent
for patients where we're looking
for long-term seizure control.